For research use only. Not for therapeutic Use.
Sotatercept (mIgG2a) has direct cardioprotective actions, which reduces right ventricular (RV) remodeling and improves function in a pulmonary artery banding (PAB) mouse model[1].
| Catalog Number | I040096 |
| Purity | ≥95% |
| Reference | [1]. Joshi S R, et al. Sotatercept Analog RAP-011 Inhibits Right Ventricular Remodeling and Restores Function in a Mouse Model of Pressure Overload. Circulation. 2020, 142(Suppl_3): A14397-A14397. |
.gif)